Increased time from neoadjuvant chemoradiation to surgery is associated with higher pathologic complete response rates in esophageal cancer

Annals of Thoracic Surgery

Volumn 99, Issue 1, 2015, Pages 270-276

  Shaikh, Talha ^a   Ruth, Karen ^a   Scott, Walter J ^a   Burtness, Barbara A ^a   Cohen, Steven J ^a   Konski, Andre A ^b   Cooper, Harry S ^a   Astsaturov, Igor ^a   Meyer, Joshua E ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b The Chester County Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; PACLITAXEL;

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURGERY; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; FOLLOW UP; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORBIDITY; MULTIMODALITY CANCER THERAPY; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RADIATION DOSE; RETROSPECTIVE STUDY; TIME; TREATMENT DURATION; TREATMENT RESPONSE; ESOPHAGEAL NEOPLASMS; MIDDLE AGED; NEOADJUVANT THERAPY; TIME FACTOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CHEMORADIOTHERAPY, ADJUVANT; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 84920672906     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2014.08.033     Document Type: Article

References (21)

1. T.N. Walsh, M. Grennell, S. Mansoor, and A. Kelly Neoadjuvant treatment of advanced stage esophageal adenocarcinoma increases survival Dis Esophagus 15 2002 121 124
2. S.G. Urba, M.B. Orringer, A. Turrisi, M. Iannettoni, A. Forastiere, and M. Strawderman Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma J Clin Oncol 19 2001 305 313
3. C. Apinop, P. Puttisak, and N. Preecha A prospective study of combined therapy in esophageal cancer Hepatogastroenterology 41 1994 391 393
4. J. Tepper, M.J. Krasna, and D. Niedzwiecki Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: Calgb 9781 J Clin Oncol 26 2008 1086 1092
5. P. van Hagen, M.C. Hulshof, and J.J. van Lanschot Preoperative chemoradiotherapy for esophageal or junctional cancer N Engl J Med 366 2012 2074 2084
6. V. Oppedijk, A. van der Gaast, and J.J. van Lanschot Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the cross trials J Clin Oncol 32 2014 385 391
7. L.R. Chirieac, S.G. Swisher, and J.A. Ajani Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation Cancer 103 2005 1347 1355
8. A.C. Berger, J. Farma, and W.J. Scott Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival J Clin Oncol 23 2005 4330 4337
9. M. Stahl, M.K. Walz, and M. Stuschke Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction J Clin Oncol 27 2009 851 856
10. S. Edge, D.R. Byrd, C.C. Compton, A.G. Fritz, F.L. Greene, and A. Trotti American Joint Committee on Cancer. AJCC cancer staging handbook and manual 7th ed. 2010 Springer New York
11. L. Kleinberg, J.P. Knisely, and R. Heitmiller Mature survival results with preoperative cisplatin, protracted infusion 5-fluorouracil, and 44-Gy radiotherapy for esophageal cancer Int J Radiat Oncol Biol Phys 56 2003 328 334
12. X. Zhang, D.I. Watson, G.G. Jamieson, C. Lally, J.R. Bessell, and P.G. Devitt Outcome of oesophagectomy for adenocarcinoma of the oesophagus and oesophagogastric junction Aust NZ J Surg 75 2005 513 519
13. T.N. Walsh, N. Noonan, D. Hollywood, A. Kelly, N. Keeling, and T.P. Hennessy A comparison of multimodal therapy and surgery for esophageal adenocarcinoma N Engl J Med 335 1996 462 467
14. Y. Francois, C.J. Nemoz, and J. Baulieux Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon r90-01 randomized trial J Clin Oncol 17 1999 2396
15. M.F. Kalady, L.F. de Campos-Lobato, and L. Stocchi Predictive factors of pathologic complete response after neoadjuvant chemoradiation for rectal cancer Ann Surg 250 2009 582 589
16. C.H. Chiu, Y.K. Chao, and H.K. Chang Interval between neoadjuvant chemoradiotherapy and surgery for esophageal squamous cell carcinoma: does delayed surgery impact outcome? Ann Surg Oncol 20 2013 4245 4251
17. W. Tessier, C. Gronnier, and M. Messager Does timing of surgical procedure after neoadjuvant chemoradiation affect outcomes in esophageal cancer? Ann Thorac Surg 97 2014 1181 1189
18. J.Y. Kim, A.M. Correa, and A.A. Vaporciyan Does the timing of esophagectomy after chemoradiation affect outcome? Ann Thorac Surg 93 2012 207 213
19. N.P. Rizk, E. Venkatraman, and M.S. Bains American Joint Committee on Cancer Staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma J Clin Oncol 25 2007 507 512
20. M. Koshy, B.D. Greenwald, and P. Hausner Outcomes after trimodality therapy for esophageal cancer: the impact of histology on failure patterns Am J Clin Oncol 34 2011 259 264
21. S.R. Markar, A. Bodnar, J. Rosales, G. Song, and D.E. Low The impact of neoadjuvant chemoradiotherapy on perioperative outcomes, tumor pathology, and survival in clinical stage II and III esophageal cancer Ann Surg Oncol 20 2013 3935 3941